KR102223018B1 - 수학적 모형 함수로서 환자-특이적 투여법을 제공하는 시스템 및 방법 - Google Patents

수학적 모형 함수로서 환자-특이적 투여법을 제공하는 시스템 및 방법 Download PDF

Info

Publication number
KR102223018B1
KR102223018B1 KR1020157011564A KR20157011564A KR102223018B1 KR 102223018 B1 KR102223018 B1 KR 102223018B1 KR 1020157011564 A KR1020157011564 A KR 1020157011564A KR 20157011564 A KR20157011564 A KR 20157011564A KR 102223018 B1 KR102223018 B1 KR 102223018B1
Authority
KR
South Korea
Prior art keywords
patient
model
delete delete
dosing regimen
drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020157011564A
Other languages
English (en)
Korean (ko)
Other versions
KR20150100626A (ko
Inventor
다이앤 몰드
Original Assignee
다이앤 몰드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 다이앤 몰드 filed Critical 다이앤 몰드
Priority to KR1020217005789A priority Critical patent/KR102370479B1/ko
Publication of KR20150100626A publication Critical patent/KR20150100626A/ko
Application granted granted Critical
Publication of KR102223018B1 publication Critical patent/KR102223018B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G06N7/005
    • GPHYSICS
    • G06COMPUTING OR CALCULATING; COUNTING
    • G06NCOMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
    • G06N7/00Computing arrangements based on specific mathematical models
    • G06N7/01Probabilistic graphical models, e.g. probabilistic networks
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/50ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for simulation or modelling of medical disorders

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Primary Health Care (AREA)
  • Data Mining & Analysis (AREA)
  • General Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Theoretical Computer Science (AREA)
  • Pathology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Databases & Information Systems (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Algebra (AREA)
  • Probability & Statistics with Applications (AREA)
  • General Engineering & Computer Science (AREA)
  • Computing Systems (AREA)
  • Pure & Applied Mathematics (AREA)
  • Mathematical Optimization (AREA)
  • Mathematical Analysis (AREA)
  • Evolutionary Computation (AREA)
  • Computational Mathematics (AREA)
  • Artificial Intelligence (AREA)
  • Mathematical Physics (AREA)
  • Software Systems (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
KR1020157011564A 2012-10-05 2013-10-07 수학적 모형 함수로서 환자-특이적 투여법을 제공하는 시스템 및 방법 Active KR102223018B1 (ko)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020217005789A KR102370479B1 (ko) 2012-10-05 2013-10-07 수학적 모형 함수로서의 환자-특이적 투여법용 의약

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261710330P 2012-10-05 2012-10-05
US61/710,330 2012-10-05
PCT/US2013/063691 WO2014055978A1 (en) 2012-10-05 2013-10-07 System and method for providing patient-specific dosing as a function of mathematical models

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1020217005789A Division KR102370479B1 (ko) 2012-10-05 2013-10-07 수학적 모형 함수로서의 환자-특이적 투여법용 의약

Publications (2)

Publication Number Publication Date
KR20150100626A KR20150100626A (ko) 2015-09-02
KR102223018B1 true KR102223018B1 (ko) 2021-03-05

Family

ID=50433375

Family Applications (3)

Application Number Title Priority Date Filing Date
KR1020157011564A Active KR102223018B1 (ko) 2012-10-05 2013-10-07 수학적 모형 함수로서 환자-특이적 투여법을 제공하는 시스템 및 방법
KR1020227006798A Active KR102450486B1 (ko) 2012-10-05 2013-10-07 수학적 모형 함수로서 환자-특이적 투여법을 제공하는 시스템 및 방법
KR1020217005789A Active KR102370479B1 (ko) 2012-10-05 2013-10-07 수학적 모형 함수로서의 환자-특이적 투여법용 의약

Family Applications After (2)

Application Number Title Priority Date Filing Date
KR1020227006798A Active KR102450486B1 (ko) 2012-10-05 2013-10-07 수학적 모형 함수로서 환자-특이적 투여법을 제공하는 시스템 및 방법
KR1020217005789A Active KR102370479B1 (ko) 2012-10-05 2013-10-07 수학적 모형 함수로서의 환자-특이적 투여법용 의약

Country Status (9)

Country Link
US (7) US10083400B2 (https=)
EP (2) EP2904388B1 (https=)
JP (5) JP6412499B2 (https=)
KR (3) KR102223018B1 (https=)
AU (5) AU2013326801A1 (https=)
CA (1) CA2887072C (https=)
IL (3) IL238115B (https=)
SG (2) SG10201907682RA (https=)
WO (1) WO2014055978A1 (https=)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9238100B2 (en) 2012-06-07 2016-01-19 Tandem Diabetes Care, Inc. Device and method for training users of ambulatory medical devices
SG10201907682RA (en) 2012-10-05 2019-10-30 Mould Diane System and method for providing patient-specific dosing as a function of mathematical models
US9238144B2 (en) * 2013-03-14 2016-01-19 Neuropace, Inc. Optimizing data retrieval from an active implantable medical device
US10325687B2 (en) * 2013-12-06 2019-06-18 Bioverativ Therapeutics Inc. Population pharmacokinetics tools and uses thereof
US9667321B2 (en) * 2014-10-31 2017-05-30 Pearson Education, Inc. Predictive recommendation engine
US10713225B2 (en) 2014-10-30 2020-07-14 Pearson Education, Inc. Content database generation
ITMI20142149A1 (it) * 2014-12-16 2016-06-16 L I A Di Giuseppe Capasso Apparato di diagnosi differenziale in medicina adattato per determinare la sequenza di test ottimale atta ad identificare una patologia secondo criteri di appropriatezza diagnostica
WO2016149529A1 (en) * 2015-03-18 2016-09-22 The Regents Of The University Of California Phenotypic personalized medicine: adaptive optimization of patient-specific combination therapy
CA2988724C (en) 2015-04-09 2023-10-10 Diane R. Mould Systems and methods for patient-specific dosing
US20190057762A1 (en) * 2016-02-26 2019-02-21 Toyosaki Accounting Office Co., Ltd. Information processing device
CA3020346A1 (en) 2016-04-15 2017-10-19 Baxalta Incorporated Method and apparatus for providing a pharmacokinetic drug dosing regimen
US10896749B2 (en) 2017-01-27 2021-01-19 Shire Human Genetic Therapies, Inc. Drug monitoring tool
GB201708624D0 (en) * 2017-05-31 2017-07-12 Sensidose Ab System for evaluating dosage parameters
US20190065684A1 (en) * 2017-08-24 2019-02-28 Fitmylife Health Analytics Inc. Computer program products, methods, and systems for assisting a user to achieve a health-related goal
WO2019042789A1 (en) * 2017-08-30 2019-03-07 Koninklijke Philips N.V. CORONARY ARTERY HEALTH PREDICTION BASED ON MODEL AND IMAGING DATA
US10803540B2 (en) 2018-03-14 2020-10-13 Motorola Solutions, Inc. System for validating and appending incident-related data records in a distributed electronic ledger
WO2019195733A1 (en) * 2018-04-05 2019-10-10 University Of Maryland, Baltimore Method and apparatus for individualized administration of medicaments for delivery within a therapeutic range
SG11202009719XA (en) * 2018-04-23 2020-10-29 Diane Mould Systems and methods for modifying adaptive dosing regimens
WO2019213619A1 (en) 2018-05-04 2019-11-07 Abbott Laboratories Hbv diagnostic, prognostic, and therapeutic methods and products
WO2020002478A1 (en) * 2018-06-28 2020-01-02 Koninklijke Philips N.V. Method and system for personalized hypertension treatment
US10810293B2 (en) * 2018-10-16 2020-10-20 Motorola Solutions, Inc. Method and apparatus for dynamically adjusting biometric user authentication for accessing a communication device
CN111104054B (zh) * 2018-10-29 2023-10-27 伊姆西Ip控股有限责任公司 管理输入/输出操作的方法、装置和计算机程序产品
BE1027052A1 (fr) * 2019-02-14 2020-09-07 Aardex Group Procede d'assistance a la prise ou a l'acte d'un traitement therapeutique
KR102839034B1 (ko) * 2019-03-08 2025-07-28 다이앤 몰드 약물-불특정 환자별 투여 요법을 위한 시스템 및 방법
JP7633176B2 (ja) * 2019-03-31 2025-02-19 レズメド インコーポレイテッド ユーザからの1つ以上の分析物を分析する方法、及びシステム
KR102062157B1 (ko) * 2019-04-29 2020-01-03 오케스트로 주식회사 가상 머신 배치 방법 및 이를 구현하는 가상 머신 배치 장치
JP7342491B2 (ja) * 2019-07-25 2023-09-12 オムロン株式会社 推論装置、推論方法、及び推論プログラム
KR102527404B1 (ko) * 2019-10-29 2023-05-02 고려대학교 산학협력단 인슐린 투여량 조절 방법
US11823782B2 (en) 2020-03-03 2023-11-21 Optum, Inc. Systems, methods, apparatuses, and computer program products for administering pain management solutions remotely
US11075010B1 (en) 2020-03-19 2021-07-27 Insight RX, Inc. Pharmacology model optimization based on distributed data acquisition
WO2021192971A1 (ja) * 2020-03-27 2021-09-30 テルモ株式会社 生体機能推定装置及び生体機能推定方法
US20210304846A1 (en) * 2020-03-29 2021-09-30 Stephen J. Brown Personalized compounding of therapeutic components and tracking of their influence on a measured parameter using a complex interaction model
CN115398559A (zh) * 2020-04-29 2022-11-25 诺华股份有限公司 用于评估患者眼睛中疾病或病症的活动水平的计算机实施的系统和方法
US20210375455A1 (en) * 2020-05-27 2021-12-02 MediSync, Inc. Artificial intelligence systems that incorporate expert knowledge related to heart failure
US12205705B2 (en) * 2020-07-22 2025-01-21 Optimdosing Llc Smart nutrition dosing
KR102559883B1 (ko) * 2020-09-03 2023-07-25 한양대학교 산학협력단 마르코프 의사결정 과정을 이용하는 투약 전략 생성 방법
CA3197759A1 (en) * 2020-10-08 2022-04-14 Notal Vision Ltd. Oct guided therapy
CN116897010A (zh) * 2021-02-26 2023-10-17 韦博辛斯动力公司 用于预测化疗引起的神经病变的生物标志物
AU2022286921A1 (en) 2021-05-29 2024-01-18 Steven Molnar Systems and methods for monoclonal antibody nomograms
KR20230036545A (ko) 2021-09-07 2023-03-14 서울대학교산학협력단 적응적 설계 최적화 기반으로 하는 실험 최적화 시스템 및 그 방법
US12046341B2 (en) * 2021-10-05 2024-07-23 Bradford Rabin Methods and systems for electronically adjusting a dosing pattern of a patient undergoing a medical regimen
KR102815903B1 (ko) * 2021-12-21 2025-05-30 충남대학교산학협력단 감염 환자에서 반코마이신 최적 용량을 결정하는 방법
KR102821516B1 (ko) * 2022-02-28 2025-06-17 한국전자기술연구원 목표 농도 조절 주입을 지원하는 약물 투여 장치 및 방법
US20250312243A1 (en) * 2022-04-28 2025-10-09 Regents Of The University Of Michigan Closed-loop architecture for distributing and administering medicines to patients
KR102447046B1 (ko) * 2022-06-03 2022-09-26 주식회사 인투인월드 인공지능 기반 임상시험 프로토콜 설계 방법, 장치 및 시스템
US12073931B2 (en) * 2022-06-15 2024-08-27 Express Scripts Strategic Development, Inc. Alternate dose regimen identification system
EP4587840A1 (en) 2022-09-15 2025-07-23 Abbott Laboratories Hbv diagnostic, prognostic, and therapeutic methods and products
KR102873330B1 (ko) * 2022-09-23 2025-10-21 재단법인 아산사회복지재단 머신러닝 기술을 활용한 항응고제 초기 적정 용량 예측 방법 및 장치

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060036619A1 (en) 2004-08-09 2006-02-16 Oren Fuerst Method for accessing and analyzing medically related information from multiple sources collected into one or more databases for deriving illness probability and/or for generating alerts for the detection of emergency events relating to disease management including HIV and SARS, and for syndromic surveillance of infectious disease and for predicting risk of adverse events to one or more drugs
JP2012123837A (ja) * 2005-11-29 2012-06-28 Children's Hospital Medical Center 薬物選択及び投薬の最適化及び個別化

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5694950A (en) 1992-08-21 1997-12-09 J & W Mcmichael Software, Inc. Method and system for use in treating a patient with immunosuppresants using whole blood level criteria to prevent an adverse immune response
US5365948A (en) 1992-08-21 1994-11-22 J & W Mcmichael Software Inc. Method for use in treating a patient with FK 506 to prevent an adverse immune response
US6575169B2 (en) 1999-07-06 2003-06-10 The Rxfiles Corporation Method and apparatus for use in treating a patient with any drug to optimize therapy and prevent an adverse drug
US6581607B2 (en) 1999-07-06 2003-06-24 The Rx Files Corporation Method and system for use in treating a patient with a biological substance to optimize therapy and prevent an adverse response
US6581606B2 (en) 1999-07-06 2003-06-24 The Rx Files Corporation Method, apparatus and system for use in treating patient with a drug having an antineoplastic effect to optimize therapy and prevent an adverse drug response
US6267116B1 (en) 1999-07-06 2001-07-31 The Rxfiles Corporation Method and system for use in treating a patient with any drug to optimize therapy and prevent an adverse drug
US7585847B2 (en) 2000-02-03 2009-09-08 Coley Pharmaceutical Group, Inc. Immunostimulatory nucleic acids for the treatment of asthma and allergy
US6599281B1 (en) * 2000-05-03 2003-07-29 Aspect Medical Systems, Inc. System and method for adaptive drug delivery
AU1227302A (en) 2000-09-15 2002-03-26 Virco Nv System and method for optimizing drug therapy for the treatment of diseases
US6578582B2 (en) 2001-08-24 2003-06-17 The Rxfiles Corporation Method and apparatus using IDS™ for multi-agent therapy
US6883521B2 (en) 2001-08-24 2005-04-26 Dimensional Dosing Systems, Inc. Method and apparatus for dosing single and multi-agent therapy
US7490085B2 (en) 2002-12-18 2009-02-10 Ge Medical Systems Global Technology Company, Llc Computer-assisted data processing system and method incorporating automated learning
US20040122719A1 (en) * 2002-12-18 2004-06-24 Sabol John M. Medical resource processing system and method utilizing multiple resource type data
EP1646381A4 (en) 2003-07-02 2009-12-09 Merck & Co Inc COMBINATION THERAPY FOR THE TREATMENT OF CHRONIC INFLAMMATORY DISEASES
WO2005072792A1 (en) * 2004-01-27 2005-08-11 Aspect Medical Systems, Inc. System for adaptive drug delivery
WO2005074633A2 (en) 2004-02-03 2005-08-18 The Regents Of The University Of Michigan Compositions and methods for characterizing, regulating, diagnosing, and treating cancer
US20050187789A1 (en) 2004-02-25 2005-08-25 Cardiac Pacemakers, Inc. Advanced patient and medication therapy management system and method
US7687608B2 (en) 2005-10-19 2010-03-30 Smartcells, Inc. Methods for reducing the mitogenicity of lectin compositions
US8781566B2 (en) 2006-03-01 2014-07-15 Angel Medical Systems, Inc. System and methods for sliding-scale cardiac event detection
US8540517B2 (en) * 2006-11-27 2013-09-24 Pharos Innovations, Llc Calculating a behavioral path based on a statistical profile
US8010476B2 (en) * 2007-06-04 2011-08-30 Siemens Medical Solutions Usa, Inc. System and method for medical predictive models using likelihood gamble pricing
EP2562664B1 (en) 2007-06-27 2020-11-25 Roche Diabetes Care GmbH System for determining an insulin delivery and communicating a dose in automated pancreas software
US20110229471A1 (en) * 2008-11-26 2011-09-22 Cedars-Sinai Medical Center Methods of determining responsiveness to anti-tnf alpha therapy in inflammatory bowel disease
US20100273738A1 (en) 2009-04-23 2010-10-28 Valcke Christian P Integrated patient management and control system for medication delivery
WO2011059824A2 (en) 2009-10-29 2011-05-19 Medtronic, Inc. Methods and materials for optimized hepatitis c therapeutic regimens
US8843321B2 (en) 2010-01-26 2014-09-23 Roche Diagnostics Operations, Inc. Methods and systems for processing glucose data measured from a person having diabetes
US8679009B2 (en) 2010-06-15 2014-03-25 Flint Hills Scientific, Llc Systems approach to comorbidity assessment
US8951192B2 (en) * 2010-06-15 2015-02-10 Flint Hills Scientific, Llc Systems approach to disease state and health assessment
SG10201907682RA (en) 2012-10-05 2019-10-30 Mould Diane System and method for providing patient-specific dosing as a function of mathematical models
US20140114676A1 (en) 2012-10-23 2014-04-24 Theranos, Inc. Drug Monitoring and Regulation Systems and Methods
ES2877551T3 (es) 2013-04-24 2021-11-17 Fresenius Kabi Deutschland Gmbh Procedimiento de funcionamiento de un dispositivo de control para controlar un dispositivo de infusión
SG11201510515YA (en) 2013-06-20 2016-01-28 Baxalta Inc Providing a pharmacokinetic drug dosing regime
CA2988724C (en) 2015-04-09 2023-10-10 Diane R. Mould Systems and methods for patient-specific dosing

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060036619A1 (en) 2004-08-09 2006-02-16 Oren Fuerst Method for accessing and analyzing medically related information from multiple sources collected into one or more databases for deriving illness probability and/or for generating alerts for the detection of emergency events relating to disease management including HIV and SARS, and for syndromic surveillance of infectious disease and for predicting risk of adverse events to one or more drugs
JP2012123837A (ja) * 2005-11-29 2012-06-28 Children's Hospital Medical Center 薬物選択及び投薬の最適化及び個別化

Also Published As

Publication number Publication date
KR20220032641A (ko) 2022-03-15
IL264125A (en) 2019-01-31
JP7632886B2 (ja) 2025-02-19
JP2016500866A (ja) 2016-01-14
JP6653365B2 (ja) 2020-02-26
CA2887072C (en) 2024-04-16
EP2904388A4 (en) 2016-06-22
US10740687B2 (en) 2020-08-11
US20200334561A1 (en) 2020-10-22
IL264125B (en) 2020-03-31
US10083400B2 (en) 2018-09-25
JP6412499B2 (ja) 2018-10-24
KR20150100626A (ko) 2015-09-02
WO2014055978A1 (en) 2014-04-10
US10268966B2 (en) 2019-04-23
AU2013326801A1 (en) 2015-04-16
JP2022111352A (ja) 2022-07-29
SG11201502616WA (en) 2015-05-28
US20190171962A1 (en) 2019-06-06
US20140100829A1 (en) 2014-04-10
US20260045344A1 (en) 2026-02-12
KR20210025697A (ko) 2021-03-09
SG10201907682RA (en) 2019-10-30
KR102450486B1 (ko) 2022-10-04
EP4224482A1 (en) 2023-08-09
IL272760A (en) 2020-04-30
CA2887072A1 (en) 2014-04-10
IL272760B (en) 2022-03-01
AU2023278028A1 (en) 2023-12-21
US20180032892A1 (en) 2018-02-01
AU2026200328A1 (en) 2026-02-05
US10706364B2 (en) 2020-07-07
JP2024180539A (ja) 2024-12-26
JP2019016388A (ja) 2019-01-31
IL238115B (en) 2019-01-31
US20220044782A1 (en) 2022-02-10
EP2904388C0 (en) 2023-06-07
EP2904388B1 (en) 2023-06-07
JP2020080161A (ja) 2020-05-28
US11373743B2 (en) 2022-06-28
HK1213983A1 (en) 2016-07-15
KR102370479B1 (ko) 2022-03-04
US20140351197A1 (en) 2014-11-27
AU2021245151A1 (en) 2021-11-04
AU2019232874A1 (en) 2019-10-10
EP2904388A1 (en) 2015-08-12

Similar Documents

Publication Publication Date Title
KR102223018B1 (ko) 수학적 모형 함수로서 환자-특이적 투여법을 제공하는 시스템 및 방법
US20230178203A1 (en) Systems and methods for patient-specific dosing
Sutherland et al. Economic evaluation of a novel genetic screening test for risk of venous thromboembolism compared with standard of care in women considering combined hormonal contraception in Switzerland
HK40098325A (en) System and method for providing patient-specific dosing as a function of mathematical models
HK1213983B (en) System and method for providing patient-specific dosing as a function of mathematical models

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20150430

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
N231 Notification of change of applicant
PN2301 Change of applicant

Patent event date: 20151221

Comment text: Notification of Change of Applicant

Patent event code: PN23011R01D

A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20180928

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20200428

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20201126

A107 Divisional application of patent
GRNT Written decision to grant
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20210225

PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20210225

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20210226

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
PR1001 Payment of annual fee

Payment date: 20250219

Start annual number: 5

End annual number: 5